paediatrics Brussels 17

Treatment proposal according to the EuroNet PHL C2 Study TL2: Stage I and IIB with risk factors

At time of diagnosis

ERA

LRA

2x OEPA 2x COPDAC-28 ERA PET positive

primary Tumor extension without boost